Johnny Mahlangu to Cost-Benefit Analysis
This is a "connection" page, showing publications Johnny Mahlangu has written about Cost-Benefit Analysis.
Connection Strength
0,039
-
The evolving landscape of gene therapy for congenital haemophilia: An unprecedented, problematic but promising opportunity for worldwide clinical studies. Blood Rev. 2021 03; 46:100737.
Score: 0,039